High STI burden among a cohort of adolescents aged 12-19 years in a youth-friendly clinic in South Africa.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
    • Abstract:
      Adolescents face a higher risk for HIV, STIs, and unintended pregnancy than any other age group in sub-Saharan Africa, and have unique health care needs as they navigate this period of growth and developmental milestones. We conducted the Youth Friendly Services study among adolescents in Rustenburg, South Africa to address some of these concerns. Participants aged 12-19 were followed quarterly for 12 months, asked at baseline about demographics, their sexual behavior, and tested for HIV, STIs, and pregnancy (girls). Report of sexual activity was not a requirement for enrollment. Assent and parental consent were obtained for participants under 18. Some follow up visits fell during COVID-mandated shutdowns, and we worked with participants to reschedule and extend follow up as appropriate. Here we present data on reported behaviors, participant attrition, risk of HIV, other STI, and pregnancy. From May 2018 to August 2019, we enrolled 223 HIV-negative, non-pregnant adolescents (64% girls). The median age was 17 (IQR: 14-18). Among the 119 (53%) participants who reported being sexually active at baseline, the median age at first sex was 16 years (IQR: 15-17). During follow-up, an additional 16 (7%) participants reported having their first sexual encounter. Among the sexually active participants, the incidence of HIV was 1.5 cases / 100 person-years at risk (PYAR, 95% CI: 0.4-6.0), the incidence of chlamydia was 15.7 cases (95% CI: 10.1-24.4), gonorrhea was 4.7 cases (95% CI: 2.1-10.5), and HSV was 6.3 cases (95% CI: 3.1-12.6); we observed no cases of incident syphilis. The incidence of pregnancy among sexually active girls was 15.0 pregnancies / 100 PYAR (95% CI: 8.5-26.5). Despite small numbers, the incidence of most STIs was significantly higher in females compared to males. We also observed two pregnancies and 5 incident STIs among participants who reported never having had sex, these tended to be younger participants. From March to September 2020, the clinic was shut down for COVID-19, and 53 study visits were postponed. Follow up was concluded in November 2020, a total of 19 participants were lost to follow up, however only one participant dropped off-study during COVID-19 shutdowns. Retention at the final visit was 91.5%. We successfully completed a prospective study of adolescents to learn more about the risks they face as they navigate sexual debut in the context of a program of youth-friendly counseling and services. Among self-reported sexually active participants, we observed a high rate of HIV, STI and pregnancy, however we also observed pregnancy and STIs among those who reported no sexual activity.
      Competing Interests: The authors declare that no competing interests exist.
      (Copyright: © 2024 Price et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
    • References:
      PLoS Med. 2022 Jan 11;19(1):e1003865. (PMID: 35015777)
      Sex Transm Infect. 2023 Nov;99(7):433-439. (PMID: 36889914)
      Sex Transm Infect. 2017 Jun;93(4):259-266. (PMID: 28082662)
      Sex Transm Dis. 2015 Mar;42(3):160-1. (PMID: 25668649)
      AIDS Behav. 2012 Aug;16(6):1491-500. (PMID: 22323006)
      J Int AIDS Soc. 2019 Jul;22 Suppl 4:e25298. (PMID: 31328444)
      PLoS One. 2020 Aug 24;15(8):e0238028. (PMID: 32834018)
      J Adolesc Health. 2009 Dec;45(6):595-601. (PMID: 19931832)
      Int J Reprod Med. 2018 Jun 14;2018:1972941. (PMID: 30013978)
      PLoS One. 2015 Jan 20;10(1):e0116100. (PMID: 25602351)
      PLoS One. 2021 Dec 2;16(12):e0260126. (PMID: 34855790)
      Lancet HIV. 2021 Feb;8(2):e77-e86. (PMID: 33539761)
      J Acquir Immune Defic Syndr. 2020 Feb 1;83(2):135-139. (PMID: 31929401)
      Int Health. 2022 Nov 1;14(6):545-553. (PMID: 35134172)
      J Clin Res Pediatr Endocrinol. 2020 Feb 06;12(Suppl 1):28-40. (PMID: 32041390)
      J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):726-33. (PMID: 15167292)
      JAMA Psychiatry. 2021 Aug 1;78(8):829-837. (PMID: 34106239)
      J Pediatr Adolesc Gynecol. 2014 Apr;27(2):50-60. (PMID: 24119658)
      Front Reprod Health. 2023 Feb 23;5:1089104. (PMID: 36910339)
      Clin Infect Dis. 2022 Nov 21;75(Suppl 4):S562-S570. (PMID: 36410381)
      J Adolesc Health. 2021 Mar;68(3):623-625. (PMID: 32807593)
      BMC Health Serv Res. 2018 Oct 22;18(1):809. (PMID: 30348166)
      PLoS Med. 2018 Feb 27;15(2):e1002511. (PMID: 29485986)
      PLoS Med. 2018 Feb 27;15(2):e1002512. (PMID: 29485985)
      BMC Public Health. 2020 Nov 25;20(1):1789. (PMID: 33239018)
      J Int AIDS Soc. 2015 Feb 26;18(2 Suppl 1):19393. (PMID: 25724503)
      AIDS. 2021 Mar 1;35(3):369-380. (PMID: 33181534)
      Lancet Glob Health. 2019 Nov;7(11):e1521-e1540. (PMID: 31607465)
      Reprod Health Matters. 2001 May;9(17):160-9. (PMID: 11468833)
      S Afr Med J. 2018 Mar 28;108(4):291-298. (PMID: 29629679)
      BMC Med Res Methodol. 2023 Jan 16;23(1):16. (PMID: 36647003)
      BMJ Open. 2012 Feb 13;2(1):e000626. (PMID: 22331388)
      J Acquir Immune Defic Syndr. 2012 Feb 1;59(2):185-93. (PMID: 22227488)
      J Adolesc Health. 2023 Apr;72(4):568-574. (PMID: 36658009)
    • Grant Information:
      UM1 AI154463 United States AI NIAID NIH HHS
    • Publication Date:
      Date Created: 20240710 Date Completed: 20240710 Latest Revision: 20240927
    • Publication Date:
      20240927
    • Accession Number:
      PMC11236123
    • Accession Number:
      10.1371/journal.pone.0306771
    • Accession Number:
      38985722